DGAP-News: Alacris Theranostics GmbH / Key word(s): Alliance Alacris Theranostics ModCellTM system will use the SAP HANA(R) platform to speed up in silico modeling of drug responses during patient treatments as well as for drug development and approval. 01.04.2014 / 09:30 --------------------------------------------------------------------- Press Release ______________________________________________________________ Alacris Theranostics ModCellTM system will use the SAP HANA(R) platform to speed up in silico modeling of drug responses during patient treatments as well as for drug development and approval. ______________________________________________________________ Berlin, 1st April 2014 - Alacris Theranostics has entered into a project with SAP AG (NYSE: SAP) to use the SAP HANA(R) platform to enable Alacris' proprietary ModCellTM system. This model is used for drug stratification and identification of personalized drug treatments for cancer patients. The work began through a joint project between Alacris and the SAP(R) Innovation Center in Germany. SAP will provide Alacris with SAP HANA and accessory software modules and will tailor them in collaboration with Alacris to meet the needs of ModCellTM applications. Using SAP HANA is expected to accelerate the modelling and prediction of drug action by Alacris' ModCellTM system by a factor of several thousand. This allows - in only a few minutes - to identify relevant drugs and simulate their effect on individual patients during cancer treatment, based on highly complex genome and transcriptome data. This speed-up has the potential to be a major factor in helping Alacris bring its ModCellTM applications into a broader clinical use. Moreover, by using SAP HANA Alacris expects to improve the performance of complex tasks such as simulations of single and combinatory drug action throughout the drug development and approval processes. Saving both time and computational resources for the simulations could potentially help pharmaceutical companies reach decisions sooner during drug development and approval, saving significant time and money. Through this project, Alacris will be expanding the use of SAP HANA into the field of personalized medicine and to the forefront of systems biology modeling using next-generation sequencing data. About Alacris Theranostics GmbH: Alacris Theranostics (www.alacris.de) is a company based in Berlin specialized in developing new approaches in personalized medicine for cancer patient diagnosis, treatment and drug stratification. Alacris Theranostics is applying a systems biology approach exclusively licensed as ModCellTM to Alacris. Based on genome and transcriptome information obtained by next generation sequencing and including kinetic pathway information, mutation and drug databases, the systems biology approach is providing a "Virtual Patient" model. The "Virtual Patient" model can predict the effect of drug treatment and optimized combinatory treatment providing means for truly personalized medicine approaches. In addition, Alacris' "Virtual Clinical Trials" system permits the in silico analysis of drugs, thus identifying stratified patient groups with particular genetic and molecular profiles that could be targeted by the drug, with the goal of more efficient drug development and approval. # # # SAP, SAP HANA and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries. All other product and service names mentioned are the trademarks of their respective companies. Contact: Alacris Theranostics GmbH Dr Bodo Lange, CEO Fabeckstrasse 60-62 D-14195 Berlin Germany Phone: + 49 30 8431 22 510 Email: info@alacris.de www.alacris.de MC Services AG Anne Hennecke, Managing Partner Phone +49 211 529 252 22 Email: anne.hennecke@mc-services.eu End of Corporate News --------------------------------------------------------------------- 01.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 260789 01.04.2014
DGAP-News: Alacris Theranostics ModCellTM system will use the SAP HANA(R) platform to speed up in silico modeling of drug responses during patient treatments as well as for drug development and approval.
| Source: EQS Group AG